Search PubMed⌕ Search

Biomedical subjects

J P Pascal

Publications and source records attributed to J P Pascal.

At least 91 records · Page 5Linked to original sources
PubMed1982

Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis.

As the clinical significance of hemodynamic parameters remains controversial, the portohepatic gradient has been measured in 89 patients with cirrhosis by a transjugular approach. Relationships between portohepatic gradient and clinical, roentgenologic and prognostic patterns were studied with a maximum follow-up period of 36 months. Portohepatic gradient was not related to the rate of occurrence or rate of recurrence of digestive tract bleeding. Portohepatic gradient was related to the size of esophageal varices, p less than 0.01. Observation of large varices at endoscopy was associated with a higher risk of digestive tract bleeding. Portohepatic gradient was related to the number of portosystemic shunts opacified at portography, p less than 0.01. Portohepatic gradient was found to be related to these aspects of prognosis: the mean portohepatic gradient was higher in patients who died than it was in survivors, p less than 0.05. When patients were separated into two groups according to portohepatic gradient values--greater than or equal to 20.8, less than 20.8 millimeters of mercury--the actuarial survival rate was inversely related to portohepatic gradient at one, p less than 0.02, and at 12, p less than 0.02, months of follow-up study. This relationship could be demonstrated in the entire group of patients with cirrhosis and in the group of patients with digestive tract bleeding. This pattern seemed to be related to the risk of hemorrhage. In groups of patients and within a 24 month observation period, the survival rate was significantly related to the range of portohepatic gradient in each group.

Aged↗
PubMed1980

[Position of dietary factors in large bowel cancers (author's transl)].

Epidemiological studies suggest that environmental factors, especially dietary ones, are more relevant in the causation of large bowel cancer than host factors. High meat and high-fat, low-fiber and low-vegetable diets appear to be the most plausible etiological candidates. Metabolic epidemiology and experimental studies point out that changes in the composition of the intestinal bacteria and of the neutral sterol and bile acid excretion are likely to yield colon tumor promoters. Implications of the available data are discussed in terms of colon cancer prevention.

Colonic Neoplasms↗
PubMed1978

Action of dopamine on cyclic AMP-tissue level in the rat pancreas. Interaction with secretin.

Dopamine increased the cyclic AMP content of rat pancreas slices. It only partially displayed the agonist activity of secretin. Haloperidol 10(-4)M, a dopamine blocking agent almost completely inhibited the response to dopamine but had no effect on the response to secretin. Dopamine 10(-3)M, increased the cyclic AMP level induced by a low concentration of secretin and inhibited the production of cyclic AMP observed with a high concentration of secretin. Our data suggest that dopamine in the rat pancreatic tissue does not interfere with the secretin receptor but might act on the same adenylate cyclase.

Animals↗
PubMed1977

In-situ-isolated perfused rat pancreas: a new method for pharmacological studies of the exocrine pancreas.

A method of in-situ-isolated perfused rat pancreas is described. In situ perfusion of the isolated rat pancreas allows a faster set-up, thanks to a simpler operating procedure. The sensitivity of the isolated rat pancreas has been tested with secretin and cholecystokinin. The pancreas responds to doses of secretin as low as 0.005 CU/kg-h. Such a highly sensitive model might prove to be useful for the bioassay of secretin and the study of the effects of pancreatic secretagogues.

Animals↗
PubMed1977

Effects of catecholamines and their inhibitors on the isolated canine pancreas. I. Noradrenaline and isoprenaline.

alpha Adrenergic agonist (noradrenaline, 2, 20, and 200 mug) and antagonist (phenoxybenzamine, 15 mg), and beta adrenergic agonist (isoproterenol, 2, 20, and 200 mug), and antagonist (propranolol, 6 mg), were tested on isolated perfused canine pancreas under basal conditions, and under stimulation by a background of secretin (0.5 clinical unit per hr), or of caerulein (600 to 1200 ng per hr). Noradrenaline induced a strong vasoconstriction (inhibited by phenoxybenzamine), followed by a moderate vasodilation (possibly mechanical). Noradrenaline did not stimulate a resting pancreas and inhibited a pancreas from secreting in response to secretin or caerulein. After phenoxybenzamine, in the absence of vasoconstriction, this latter effect was reversed into a dose-dependent stimulation of hydrelatic secretion, suggesting that noradrenaline had a direct action on the secretory cell. There was no stimulation of protein and no acinar degranulation. Propranolol and atropine did not modify the effectiveness of noradrenaline. Isoprenaline had a weak vasodilatory effect but no effect on the secretion. Adrenergic blocking agents did not alter the response to secretin or caerulein.

Animals↗
PubMed1977

Effects of catecholamines and their inhibitors on the isolated canine pancreas. II. Dopamine.

Dopaminergic agonists (dopamine, 2, 10, 50, and 250 mug; apomorphine, 1 mg; noradrenaline, 2, 20, and 200 mug), and inhibitors (haloperidol, 5 mg; pentamethonium, 500 mg; phenoxybenzamine, 15 mg, and atropine sulfate, 10 mg), were tested on isolated perfused canine pancreas; under basal conditions and under stimulation by a background of secretin (0.1, 0.5, and 10.0 clinical unit per hr), or of caerulein (1200 ng per hr). Low doses of dopamine induced a vasodilation inhibited by haloperidol Large doses induced a vasoconstriction, presumably by stimulation of alpha adrenergic receptors. Dopamine stimulated hydrelatic secretion. The calculated maximal response was about one-half that of secretin. This response was inhibited by haloperidol but not by atropine, pentamethonium, and phenoxybenzamine. No acinar degranulation was observed after stimulation by dopamine. The response to secretin was not altered by haloperidol. It was concluded that blood vessels and pancreatic tissue contain specific receptors to dopamine different from secretin receptors. Secretory response to noradrenaline after phenoxy benzamine was inhibited by haloperidol, suggesting that this effect was mediated by the stimulation of dopamine receptors of the cells. A hypothetical representation of the interrelation between dopamine, secretin, and noradrenaline is discussed.

Animals↗
PubMed1976

[Clinical aspects and course of drug-induced upper digestive hemorrhage].

In a series of 500 patients admitted to hospital for upper digestive hemorrhage, the authors studied the influence of taking drugs on the clinical characteristics and course of the original disease. Taking aspirin is exceptional before rupture of esophageal varices. One may isolate a homogenous group of elderly women consuming aspirin and another anti-inflammatory drug, and bleeding from a gastric ulcer. One may also isolate another group of men, bleeding from acute gastro-duodenal lesions after taking aspirin alone. If one considers apart portal hypertension, owing to its extreme gravity, one may note that the prognosis depends on the age. One patient out of five, dies of hemorrhage after the age of 60 years. Taking an anti-inflammatory drug at this age is thus not harmless.

Adrenal Cortex Hormones↗
PubMed1976

[Cholestatic hepatitis with a chronic course. 7 cases].

Cholestatic hepatitis, whilst having a longer course than cytolytic forms, in general regresses in a few months. The authors report here seven cases of cholestatic hepatitis lasting for more than 18 months. These chronic forms have certain characteristic features: - female predominance (6 cases out of 7). - a severe degree of cholestasis with, in particular, marked elevation of lipids, cholesterol and alkaline phosphatase. - the absence of Australia antibody and antigen, together with the absence of anti-smooth muscle antibody and anti-mitochondrial natibody. - a decrease in the number of permeable biliary canaliculi in the portal spaces. - a decrease in the number of permeable biliary canaliculi in the portal spaces. - a course which appears to be little influenced by various therapeutic measures. Although the final course seems satisfactory on the majority of cases, the possibility of a slow cirrhogenic transformation cannot be excluded in certain instances.

Adult↗